Health programs on the GOP chopping block

Presented by AMAC Action: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Jan 13, 2025 View in browser
 
POLITICO Pulse Newsletter Header

By Chelsea Cirruzzo

Presented by 

With Ben Leonard

Driving The Day

Sen. Lisa Murkowski talks to reporters as she walks in the Capitol.

Many GOP lawmakers want to let ACA health insurance plan subsidies expire, but GOP Sen. Lisa Murkowski feels differently. | Francis Chung/POLITICO

GOP FLOATS HEALTH CARE CUTS — House Republicans are circulating a menu of options amounting to more than $5 trillion in cuts they could use to bankroll President-elect Donald Trump’s top priorities this year.

On the table: changes to Medicare, Medicaid and the Affordable Care Act. The list from the House Budget Committee could be used to finance a party-line reconciliation bill or other spending reduction efforts. The proposed cuts are highly ambitious, but not all are likely to become law, given the narrow margins for Republicans in the House and Senate.

I caught up with POLITICO Congress reporter and former Pulse author Ben Leonard to discuss the state of play.

There would be a few different ways on this “menu” to cut Medicaid. Can you walk us through them? 

One big target is per-capita caps, favored by House Energy and Commerce Chair Brett Guthrie (R-Ky.). They’d allocate a set amount of Medicaid funding based on population instead of being an open-ended entitlement. That’s projected to save up to $918 billion.

Another major target is equalizing payments for nondisabled adults with those of traditional Medicaid enrollment — those with disabilities or low-income children, which [Republicans] say would save up to $690 billion.

Adding work requirements in the program is also on the table and is pegged to save $120 billion.

Which ones would get the most opposition from Dems?

They’d pretty much all be nonstarters for Democrats and even some Republicans. Medicaid insures more than 70 million Americans, and any legislation that might reduce coverage in the program would be fiercely opposed by Democrats and could be a tough vote for Republicans in swing districts.

The proposed ACA changes involve enhanced premium tax credits that expire at the end of the year, setting up a major policy battle. 

Democrats broadly support extending the enhanced subsidies, which have lowered premium costs for many Americans and led to record ACA marketplace enrollment. Many Republicans support letting them expire, arguing they’re raising health care costs, but moderate Sen. Lisa Murkowski (R-Alaska) recently said she supports extending them. Either way, Republicans will have a difficult choice: spend hundreds of billions to buoy Obamacare enrollment or raise premium costs significantly heading into an election year in 2026.

Are there any proposals that could get bipartisan agreement?

Site-neutral payments are a more bipartisan option under consideration. Limiting eligibility for ACA plans based on citizenship status could receive more bipartisan interest than it might have previously, given Democrats’ pivot on immigration after a tough election cycle. But most of the options are not expected to receive much, if any, Democratic support.

WELCOME TO MONDAY PULSE. Even before the surgeon general’s warning about alcohol, a lot of Americans were drinking less — including your newsletter writer, who is doing Dry January. This weekend, I experimented with nonalcoholic drink options by mixing homemade syrups, including galangal and lemongrass, with ginger ale. I’d highly recommend it! Send your tips, scoops and feedback to ccirruzzo@politico.com and follow along @ChelseaCirruzzo.

A message from AMAC Action:

The Inflation Reduction Act took billions from the Medicare Part D prescription drug program to fund electric vehicle tax credits and green energy investments, and now seniors’ prescription drug premiums are skyrocketing. Seniors are calling on Congress to pause the Inflation Reduction Act and return those funds back to Medicare where they belong. Visit PauseTheIRA.com.

 
Public Health

Dr. Deborah Birx testifies before a House subcommittee.

Dr. Deborah Birx is urging Congress to reauthorize PEPFAR. | Kevin Wolf/AP

A PEPFAR PLEA — America’s largest global health program that fights HIV in the developing world expires in two months, and the Bush Institute is urging the incoming Trump administration to protect it, POLITICO’s Carmen Paun reports.

The institute, an arm of the George W. Bush Presidential Center, said Congress should reauthorize the President’s Emergency Plan for AIDS Relief that Bush created when he was president.

The law should extend PEPFAR for another five years, the institute said in a set of recommendations written by former PEPFAR coordinator — and former Trump White House coronavirus response coordinator — Dr. Deborah Birx and Hannah Johnson, the institute’s global policy program manager.

“Abruptly scaling back or losing focus would risk U.S. taxpayers’ investments and the people served by PEPFAR,” the two wrote.

They also ask President-elect Donald Trump to quickly nominate a new U.S. global AIDS coordinator — who also leads PEPFAR — and to ensure the program’s resources aren’t diverted within a global health security bureau that outgoing Secretary of State Antony Blinken created within the State Department.

Dr. John Nkengasong, the coordinator President Joe Biden appointed in 2021, is expected to resign when Trump takes office.

Why it matters: The Bush Institute’s recommendations come two months before a one-year PEPFAR reauthorization is set to expire and a week before Trump, who’s seen as skeptical of some global health investments, is set to return to the White House.

Since its creation in 2003, PEPFAR is credited with saving 25 million lives.

The program, which the U.S. funds at about $5 billion a year, has enjoyed bipartisan support, with Congress reauthorizing it three times for five years.

But for the first time, Congress re-upped it for only one year in 2024, after letting it expire in 2023, over concerns from some congressional Republicans that the Biden administration was using the program to indirectly fund abortion rights abroad.

Obamacare

SCOTUS TAKES ON ACA — The Supreme Court said it would take up a challenge to Obamacare’s coverage of preventive services in its upcoming term, POLITICO’s Alice Miranda Ollstein and Josh Gerstein report.

What the lawsuit says: The lawsuit brought by conservative Texas employers aims at the panels of experts that advise HHS on which services must be covered without cost-sharing — including preventive services.

They argue the panels are unconstitutional because their members aren’t confirmed by the Senate or chosen by a Senate-confirmed agency head. The suit separately argues that certain requirements, such as insurance coverage of the HIV prevention drug PrEP and “contraceptive methods that some regard as abortifacients,” violate the religious rights of employers.

What the Biden administration has argued: The Biden Justice Department said in its petition to the Supreme Court in September that the task force and its decade of coverage recommendations are legal and should be upheld.

Why it matters: If SCOTUS rules in favor of the employers, it would weaken the Affordable Care Act and erode the coverage of tens of millions of people who get their health insurance through their employer or Obamacare’s marketplace by removing requirements that insurers cover the full cost of services from birth control to vaccines to mental health screenings.

What’s next? It remains to be seen whether lawyers for the incoming administration will stand by the Biden team’s position or elect not to defend the panels that set the coverage requirements under the ACA, which Trump has roundly criticized. If the Justice Department doesn’t defend the arrangements, the high court could appoint another lawyer to do so.

The case will likely be set for argument in March or April and decided by the end of June.

 

A message from AMAC Action:

Advertisement Image

 
In Congress

LONG TO PARAGON — Ryan Long, former senior policy adviser to former House Speaker Kevin McCarthy, is joining the Paragon Health Institute after a stint at BGR Group, Ben reports.

Long is coming to the prominent conservative think tank as director of congressional relations and senior research fellow at a prime time for GOP policy ambitions, with full Republican control of Washington. The organization, led by former Trump administration official Brian Blase, is expected to play a significant role in shaping health policy in the second Trump administration.

He will serve as a liaison to Congress and assemble original health care research. Long told Pulse he’ll focus on issues related to innovation and market “distortions” that drive up costs in Medicare, Medicaid and the 340B drug discount program.

“The trifecta does provide an opportunity to drive a lot of the policies they’ve been discussing for a long time,” Long told Ben, pointing to site-neutral reform as a potential bipartisan target. “How do we get the Medicaid program to a more sustainable management level?”

Names in the News

Chris Kelly is joining BGR Group’s health and life science practice as a VP. He previously was health policy director for Sen. Marsha Blackburn (R-Tenn.).

Manufacturers of drugs for rare diseases have enlisted the help of veteran tax lobbyist Joshua Odintz of Holland & Knight to stave off additional cuts to a tax incentive for the development of such drugs in any reconciliation bill this year.

Victoria Gemme is now director of policy and regulatory affairs at the National Organization for Rare Disorders. She previously was assistant research director at the Duke-Margolis Institute for Health Policy.

President-elect Donald Trump announced his intention to nominate Paul Lawrence as Deputy Secretary Of Veterans Affairs. Lawrence previously served as Under Secretary for Benefits at the VA in the first Trump administration.

WHAT WE'RE READING

POLITICO’s Ruth Reader reports on a long-awaited HHS artificial intelligence strategy.

POLITICO’s Robert King reports on a proposed boost to Medicare Advantage payments.

The Washington Post reports that bird flu has been detected in poultry in Maryland and Delaware.

A message from AMAC Action:

The IRA took money from Medicare Part D to fund EV tax credits under the guise of a fake “drug price negotiation.” As premiums are skyrocketing, seniors are demanding their money back.

70% of seniors are calling on Congress to pause the Inflation Reduction Act.

85% of them want the money that was taken from Medicare to fund EV tax credits to be returned to Medicare where it belongs.

Congress: It’s time to pause the IRA and fix what it broke, first by giving money back to Medicare.

Visit PauseTheIRA.com to learn more.

 
 

Follow us on Twitter

Dan Goldberg @dancgoldberg

Chelsea Cirruzzo @chelseacirruzzo

Lauren Gardner @Gardner_LM

Sophie Gardner @sophie_gardnerj

Kelly Hooper @kelhoops

Robert King @rking_19

David Lim @davidalim

Megan Messerly @meganmesserly

Alice Miranda Ollstein @aliceollstein

Carmen Paun @carmenpaun

Daniel Payne @_daniel_payne

Ruth Reader @RuthReader

Erin Schumaker @erinlschumaker

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to salenamartine360.news1@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

Post a Comment

Previous Post Next Post